Thats the medication working as intended, not a dietary crisis
"After firing a number of shots across the bow, Novo Nordisk has settled in for the major battle." Novo Nordisk opens new front with patent suit over Hims Wegovy copies reuters.com The latest from Reuters on this tussle between Wegovy maker Novo and telehealth firm Hims: Novo Nordisk sues Hims after $49 weight-loss pill sparks FDA backlash The lawsuit, which covers Novo's weight-loss drugs in pill and injectable forms, highlights the friction between obesity drugmakers and pharmacies that mix the active ingredients, harming the earnings of the original drug manufacturers
Breast Cancer risk after bariatric surgery
Pre-workout capsules containing L-Carnitine L-Tartrate are recommended
Additionally, it has been reported that GLP-1 analogues may inhibit markers of eosinophil activation and the production of Th2 cytokines
He argues that the solution to these diseases lies not just in medical treatments but in addressing the root causes related to food production, distribution, and consumption